De Motu Cordis (DMC) today announced plans for the next stage of development with its Contract Development and Manufacturing Organization (CDMO) partner, Catalent, at Catalent’s Boston, Morrisville and San Diego sites.
Recent News
How Professor John Fraser aims to ensure that through innovation, patients thrive, not just survive
BiVACOR – a clinical-stage medical device company with world headquarters based in California and International Office based in Brisbane – is awarded US$13 million from the Australian Government’s Medical Research Future Fund grant through the Artificial Heart Frontiers Program.